Amiodarone, solution for injection, 50 mg/ml, 3 ml; Salbutamol, pressurized inhalation, 100 mcg/dose, 200 doses; Theophylline solution for injection 20 mg/ml, 5 ml; Ferrous sulfate, tablets, 80 mg; Furosemide, solution for injection, 10mg/ml, 2 ml

This tender, issued by Military Unit A2428, seeks the supply of essential pharmaceutical products. The procurement includes Amiodarone solution for injection (50 mg/ml, 3 ml), Salbutamol pressurized inhalation (100 mcg/dose, 200 doses), Theophylline solution for injection (20 mg/ml, 5 ml), Ferrous sulfate tablets (80 mg), and Furosemide solution for injection (10 mg/ml, 2 ml). These medications are categorized under CPV codes 33620000-2 (Medicines for blood and cardiovascular system diseases) and 33670000-7 (Medicines for respiratory system diseases). A key condition for participation is that the shelf life of the supplied goods upon delivery must be at least 70% of their total storage period. The contract price is inclusive of packaging, loading, and unloading to the first floor. Furthermore, by submitting a bid, participants guarantee that the country of origin for the goods will not be the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran, both at the time of delivery and contract conclusion. This ensures compliance with international trade regulations and ethical sourcing practices.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 24,500.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.